Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Urinary Bladder Neoplasms 1 Surgery 1 Stress, Psychological 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Postoperative Complications 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1 Multiple Myeloma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 Head and Neck Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Breast Cancer Invasive 1

Interventions

Specimen Handling 4 Doxorubicin 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 pazopanib 2 palbociclib 2 Radiotherapy 2 Radiation 2 Ifosfamide 2 talimogene laherparepvec 1 selinexor 1 ribociclib 1 peposertib 1 mirdametinib 1 liposomal doxorubicin 1 cemiplimab 1 abemaciclib 1 X-Rays 1 Surgical Procedures, Operative 1 Proton Therapy 1 Neoadjuvant Therapy 1 Immunoglobulin G 1 Histamine H2 Antagonists 1 Gemcitabine 1 Famotidine 1 Everolimus 1 Docetaxel 1 Angptl4 protein, mouse 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Neoadjuvant Therapy × 30 days × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡